Table 2.
Countries with advanced economies | Countries with emerging and developing economies | All countries | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(%) | Last decadea | 1stquinquennialb | Last quinquennialb | Pc | Last decadea | 1st quinquennialb | Last quinquennialb | Pc | Last decadea | 1st quinquennialb | Last quinquennialb | Pc |
TEMPERATURE MEASUREMENT METHOD | ||||||||||||
Rectal | 57 | 98 | 53 | < 0.01 | 1 | 1 | 1 | 0.79 | 5 | 98 | 4 | < 0.01 |
Oral | 2 | 1 | 2 | 0.39 | 0 | 0 | 0 | 0.35 | 1 | 1 | 1 | 0.96 |
Auricular | 18 | 8 | 14 | 0.35 | 2 | 2 | 2 | 0.59 | 6 | 9 | 6 | 0.88 |
Axillar | 8 | 1 | 10 | 0.17 | 85 | 91 | 85 | 0.10 | 33 | 1 | 19 | < 0.01 |
Touching | 38 | 17 | 38 | 0.04 | 44 | 52 | 44 | 0.13 | 42 | 17 | 42 | 0.08 |
FEVER DEFINITION | ||||||||||||
Temperature ≥38°C | 60 | 46 | 60 | 0.37 | 54 | 30 | 54 | 0.32 | 58 | 38 | 55 | 0.27 |
PHYSICAL TREATMENTS | ||||||||||||
Encourage fluid intake | 72 | 19 | 34 | 0.03 | 79 | 79d | 79d | 0.92 | 73 | 19 | 62 | 0.01 |
Light clothing | 64 | 19 | 63 | 0.03 | 35 | 21 | 35 | 0.61 | 48 | 19 | 47 | 0.17 |
Adjust room temperature | 20 | 16 | 20 | 0.97 | NA | NA | NA | NA | 20 | 16 | 20 | 0.97 |
Bathe | 31 | 32 | 28 | 0.46 | 69 | 36 | 69 | 0.02 | 36 | 32 | 34 | 0.25 |
Sponge | 24 | 50 | 64 | 0.70 | 66 | 80 | 62 | 0.53 | 36 | 38 | 67 | 0.62 |
DRUG TREATMENTS | ||||||||||||
Monotherapy | 65 | 53 | 71 | 0.46 | 75 | 65 | 75 | 0.87 | 67 | 53 | 71 | 0.22 |
Acetaminophen | 92 | 91 | 98 | < 0.01 | 71 | 83 | 71 | 0.03 | 87 | 91 | 92 | 0.09 |
Ibuprofen | 32 | 20 | 41 | 0.87 | 23 | 13 | 24 | 0.09 | 28 | 20 | 43 | 0.72 |
AAS | 1 | 60 | 1 | 0.07 | 2 | 4 | 2 | 0.09 | 1 | 60 | 1 | 0.02 |
Inverse-variance-weighted pooled frequency in the last decade;
Inverse-variance-weighted pooled frequency of the first and last quinquennials with available data;
P-value of linear regression of inverse-variance-weighted frequencies over time (in years);
Same period of study; NA, No data available; AAS, acetylsalicylic acid.